Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
This meta-analysis reported that the 10-year cumulative incidence was 6.1% for all SNs, including 3.1% for SBNs (benign) and 3.7% for SMNs (malignant), with a...
To examine the rate of and identify risk factors for vasculopathy after proton therapy in pediatric patients with central nervous system and skull base tumors...
A study by the Samsung Medical Center group, Korea. In this study 66 pediatric brain tumor patients who received either proton beam craniospinal irradiation...
Dans cette présentation en français, le Dr Paul Lesueur fait le point sur trois années d'expérience en protonthérapie pour le traitement du cancer avec le...
This is a prospective study by the group from National Cancer Center, Korea, examining the neuropsychological functioning of patients with varying types of BTs...